secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001638833-24-000143
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q3 revenue $770.4M (+14.3% YoY); adjusted EBITDA $128.6M (+21.9%)
--------------------------------------------------------------------------------

- Revenue $770.4M, +14.3% YoY; same-facility revenue +4.2% on 3.7% case growth.
- Adjusted EBITDA $128.6M, +21.9% YoY; margin 16.7%, expanding 100 bps.
- Net loss attributable to Surgery Partners was $31.7M.
- FY 2024 outlook reaffirmed: revenue >$3.075B, adjusted EBITDA >$508M.
- Cash $221.8M, revolver capacity $595.8M; total net debt/EBITDA 3.8x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/0001638833-24-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000143/sgry-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001638833-24-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer